M. Bauer

发表

Bortezomib Sensitizes Primary Human Astrocytoma Cells of WHO Grades I to IV for Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand–Induced Apoptosis

J. Meixensberger, P. Ahnert, H. Walczak, 2007, Clinical Cancer Research.

Comprehensive high-resolution genomic profiling and cytogenetics of two pediatric and one adult medulloblastoma.

J. Meixensberger, P. Ahnert, H. Kirsten, 2013, Pathology, research and practice.

Cytogenetic and molecular biological characterization of an adult medulloblastoma.

J. Meixensberger, P. Ahnert, H. Kirsten, 2007, Cancer genetics and cytogenetics.

Comprehensive cytogenetic characterization of an esthesioneuroblastoma.

J. Meixensberger, P. Ahnert, H. Kirsten, 2007, Cancer genetics and cytogenetics.

Organotypic slice cultures of human glioblastoma reveal different susceptibilities to treatments

H. Stöcker, M. Durante, J. Meixensberger, 2013, Neuro-oncology.

Detection of novel genomic aberrations in anaplastic astrocytomas by GTG-banding, SKY, locus-specific FISH, and high density SNP-array.

J. Meixensberger, P. Ahnert, H. Kirsten, 2012, Pathology, research and practice.

High resolution genomic profiling and classical cytogenetics in a group of benign and atypical meningiomas.

M. Scholz, J. Meixensberger, P. Ahnert, 2011, Cancer genetics.

Genome-wide genetic characterization of an atypical meningioma by single-nucleotide polymorphism array-based mapping and classical cytogenetics.

J. Meixensberger, P. Ahnert, H. Kirsten, 2008, Cancer genetics and cytogenetics.

Intracranial hemangiopericytoma: Case study with cytogenetics and genome wide SNP-A analysis.

J. Meixensberger, P. Ahnert, H. Kirsten, 2011, Pathology, research and practice.

Multiple meningioma with different grades of malignancy: case report with genetic analysis applying single-nucleotide polymorphism array and classical cytogenetics.

J. Meixensberger, P. Ahnert, H. Kirsten, 2011, Pathology, research and practice.

Bortezomib Sensitizes Primary Meningioma Cells to TRAIL-Induced Apoptosis by Enhancing Formation of the Death-Inducing Signaling Complex

T. Koschny, J. Meixensberger, P. Sinn, 2014, Journal of neuropathology and experimental neurology.

Bortezomib sensitizes primary human esthesioneuroblastoma cells to TRAIL-induced apoptosis

J. Meixensberger, W. Stremmel, P. Ahnert, 2010, Journal of Neuro-Oncology.

Bortezomib-Mediated Up-Regulation of TRAIL-R1 and TRAIL-R2 Is Not Necessary for but Contributes to Sensitization of Primary Human Glioma Cells to TRAIL

J. Meixensberger, P. Ahnert, H. Walczak, 2007, Clinical Cancer Research.

WHO grade related expression of TRAIL-receptors and apoptosis regulators in meningioma.

T. Koschny, P. Sinn, H. Walczak, 2015, Pathology, research and practice.

Reirradiation in progressive high-grade gliomas: outcome, role of concurrent chemotherapy, prognostic factors and validation of a new prognostic score with an independent patient cohort

J. Meixensberger, K. Hoffmann, S. Combs, 2013, Radiation oncology.

Three gangliogliomas: Results of GTG‐banding, SKY, genome‐wide high resolution SNP‐array, gene expression and review of the literature

J. Meixensberger, P. Ahnert, H. Kirsten, 2015, Neuropathology : official journal of the Japanese Society of Neuropathology.

Definition of Primary and Secondary Glioblastoma—Letter

K. Hoffmann, O. Sabri, H. Barthel, 2014, Clinical Cancer Research.